90–440 mg/dL or total–to–HDL-cholesterol ratio ≥4.0) were randomized to daily fenofibrate (200 mg; Tricor, Antara, and others) or placebo for 5 years. The groups did not differ in the ...

Following a 6 week run-in phase, patients were randomized in a double blind manner to fenofibrate (200 mg per day; n = 4895) or placebo (n = 4900). Statin and other lipid lowering medications were ...